Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 147.58 USD -1.13%
Market Cap: 7.4B USD

Wall Street
Price Targets

AXSM Price Targets Summary
Axsome Therapeutics Inc

Wall Street analysts forecast AXSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXSM is 182.31 USD with a low forecast of 149.48 USD and a high forecast of 215.25 USD.

Lowest
Price Target
149.48 USD
1% Upside
Average
Price Target
182.31 USD
24% Upside
Highest
Price Target
215.25 USD
46% Upside
Axsome Therapeutics Inc Competitors:
Price Targets
ANCR
Animalcare Group PLC
39% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
31% Downside
LOVE
Cannara Biotech Inc
110% Upside
512
Grand Pharmaceutical Group Ltd
47% Upside
2161
Jbm (Healthcare) Ltd
34% Upside
PFIZER
Pfizer Ltd
25% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
37% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
31% Upside

Revenue
Forecast

Revenue Estimate
Axsome Therapeutics Inc

The compound annual growth rate of Axsome Therapeutics Inc's revenue for the next 3 years is 59%.

N/A
Past Growth
59%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Axsome Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Axsome Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXSM's stock price target?
Price Target
182.31 USD

According to Wall Street analysts, the average 1-year price target for AXSM is 182.31 USD with a low forecast of 149.48 USD and a high forecast of 215.25 USD.

What is Axsome Therapeutics Inc's Revenue forecast?
Projected CAGR
59%

The compound annual growth rate of Axsome Therapeutics Inc's revenue for the next 3 years is 59%.

Back to Top